CRBU logo

Caribou Biosciences (CRBU) Cash From Investing

Annual CFI

-$68.18 M
+$25.07 M+26.88%

31 December 2023

CRBU Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFI

$26.52 M
+$5.32 M+25.10%

30 September 2024

CRBU Quarterly CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFI

$39.20 M
+$95.00 M+170.26%

30 September 2024

CRBU TTM CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRBU Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+26.9%+138.7%+210.3%
3 y3 years-1171.5%+1474.2%+1391.3%
5 y5 years---

CRBU Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-1171.5%+61.4%at high+115.3%at high+114.6%
5 y5 years-350.4%+61.4%at high+115.3%at high+114.6%
alltimeall time-350.4%+61.4%at high+115.3%at high+114.6%

Caribou Biosciences Cash From Investing History

DateAnnualQuarterlyTTM
Sept 2024
-
$26.52 M(+25.1%)
$39.20 M(-170.3%)
June 2024
-
$21.20 M(-7.6%)
-$55.79 M(-15.4%)
Mar 2024
-
$22.96 M(-172.9%)
-$65.93 M(-3.3%)
Dec 2023
-$68.18 M(-26.9%)
-$31.47 M(-54.0%)
-$68.18 M(+91.9%)
Sept 2023
-
-$68.48 M(-718.9%)
-$35.54 M(-244.5%)
June 2023
-
$11.06 M(-46.6%)
$24.60 M(-5703.2%)
Mar 2023
-
$20.70 M(+1669.5%)
-$439.00 K(-99.5%)
Dec 2022
-$93.25 M
$1.17 M(-114.0%)
-$93.25 M(-65.3%)
Sept 2022
-
-$8.34 M(-40.3%)
-$268.38 M(+2.4%)
June 2022
-
-$13.97 M(-80.6%)
-$261.97 M(+5.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$72.11 M(-58.5%)
-$248.48 M(+40.9%)
Dec 2021
-$176.40 M(-2872.2%)
-$173.96 M(+8913.5%)
-$176.40 M(+5710.2%)
Sept 2021
-
-$1.93 M(+298.8%)
-$3.04 M(+173.5%)
June 2021
-
-$484.00 K(+2100.0%)
-$1.11 M(+63.5%)
Mar 2021
-
-$22.00 K(-96.3%)
-$679.00 K(-110.7%)
Dec 2020
$6.36 M(-76.6%)
-$600.00 K(>+9900.0%)
$6.36 M(-8.6%)
Sept 2020
-
-$4000.00(-92.5%)
$6.96 M(-0.1%)
June 2020
-
-$53.00 K(-100.8%)
$6.97 M(-0.8%)
Mar 2020
-
$7.02 M
$7.02 M
Dec 2019
$27.23 M
-
-

FAQ

  • What is Caribou Biosciences annual cash flow from investing activities?
  • What is the all time high annual CFI for Caribou Biosciences?
  • What is Caribou Biosciences annual CFI year-on-year change?
  • What is Caribou Biosciences quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Caribou Biosciences?
  • What is Caribou Biosciences quarterly CFI year-on-year change?
  • What is Caribou Biosciences TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Caribou Biosciences?
  • What is Caribou Biosciences TTM CFI year-on-year change?

What is Caribou Biosciences annual cash flow from investing activities?

The current annual CFI of CRBU is -$68.18 M

What is the all time high annual CFI for Caribou Biosciences?

Caribou Biosciences all-time high annual cash flow from investing activities is $27.23 M

What is Caribou Biosciences annual CFI year-on-year change?

Over the past year, CRBU annual cash flow from investing activities has changed by +$25.07 M (+26.88%)

What is Caribou Biosciences quarterly cash flow from investing activities?

The current quarterly CFI of CRBU is $26.52 M

What is the all time high quarterly CFI for Caribou Biosciences?

Caribou Biosciences all-time high quarterly cash flow from investing activities is $26.52 M

What is Caribou Biosciences quarterly CFI year-on-year change?

Over the past year, CRBU quarterly cash flow from investing activities has changed by +$95.00 M (+138.73%)

What is Caribou Biosciences TTM cash flow from investing activities?

The current TTM CFI of CRBU is $39.20 M

What is the all time high TTM CFI for Caribou Biosciences?

Caribou Biosciences all-time high TTM cash flow from investing activities is $39.20 M

What is Caribou Biosciences TTM CFI year-on-year change?

Over the past year, CRBU TTM cash flow from investing activities has changed by +$74.74 M (+210.31%)